BACKGROUND: Aerobic glycolysis drives cancer progression through phosphofructokinase (PFK)-mediated regulation. The contribution of platelet-type PFK (PFKP) to head and neck squamous cell carcinoma (HNSCC) pathogenesis remains undefined. METHODS: Bioinformatic screening of 548 TCGA-HNSCC cases identified glycolysis-related prognostic genes via Cox regression, followed by experimental validation using quantitative polymerase chain reaction (qPCR) and Kaplan-Meier survival analysis in 51 clinical HNSCC tissue pairs in our center. In vitro functional assays (CCK8, colony formation, migration assays and metabolic analysis experiments), co-immunoprecipitation, ubiquitination analysis, and immunofluorescence were performed in HNSCC cell lines. PFKP-AMOTL1 interaction was validated by protein-binding studies. In vivo tumor growth was assessed using nude mice models. Clinical correlation analysis utilized HNSCC patient cohorts. Statistical significance was determined by Student's t-test and ANOVA. RESULTS: PFKP emerged as the pivotal prognostic biomarker for HNSCC, demonstrating significant upregulation at mRNA/protein levels in tumors versus normal tissues (TCGA/clinical cohorts) and correlating with reduced overall and disease-specific survival. In vitro, PFKP overexpression enhanced aerobic glycolysis and epithelial-mesenchymal transition (EMT) in HNSCC cells. Mechanistically, PFKP directly bound AMOTL1, inhibiting its ubiquitin-mediated degradation. PFKP-driven glycolysis and EMT were AMOTL1-dependent. Furthermore, PFKP promoted YAP nuclear translocation via AMOTL1, suppressing Hippo pathway activity and amplifying glycolytic flux. In vivo, elevated PFKP accelerated tumor progression and glycolytic metabolism through AMOTL1/YAP/Hippo signaling. CONCLUSIONS: PFKP remodels tumor metabolism and drives EMT in HNSCC via the AMOTL1/YAP/Hippo axis, highlighting its mechanistic and prognostic significance, and suggesting its potential as a future therapeutic target.
PFKP binding AMOTL1 promotes tumor aerobic glycolysis and epithelial-mesenchymal transition by modulating Hippo pathway in head and neck cancer.
阅读:5
作者:Wang Lingwa, Li Haiyang, Yang Yifan, Shi Qian, Feng Ling, Wang Ru, Fang Jugao
| 期刊: | Journal of Translational Internal Medicine | 影响因子: | 7.400 |
| 时间: | 2026 | 起止号: | 2026 Feb 13; 14(1):108-122 |
| doi: | 10.1515/jtim-2026-0006 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
